Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Idan Ofer’s Israel Corporation to Offer Kenon Holdings on the TASE

Idan Ofer’s Israel Corporation is making some major moves as its current CFO Avisar Paz has been appointed the company’s new CEO. At the same time the company announced that its newly spun off Kenon Holdings will offer its stock on both the New York and Tel Aviv stock exchanges.

Israel Corporation Ltd. (“Israel Corp.”) is one of Israel’s largest holding companies and a global player with over 70% of its consolidated revenues derived from worldwide operations. Its core holdings focus on industries that meet basic human, industrial and economic needs: fertilizers and specialty chemicals, energy, shipping and transportation.

Paz will replace the outgoing CEO Nir Gilad who has held that position for the past 8 years. During his tenure at the top the company lost money in part due to the failure of its investment in the electric car developer better Place. Gilad will now serve as the chairman of Israel Corp subsidiary Israel Chemicals.

During his time as CEO Gilad made almost $30 million, according to Globes.

Natan Yalovsky will take over as the new CFO.

Kenon Holdings, which was incorporated in Singapore, will be comprised of some of Israel Corp’s less profitable assets. These include chipmaker TowerJazz, shipping line Zim, Qoros Automotive — a joint venture between Israel Corp and China’s Chery Automobile — IC Power and IC Green Energy. Israel Corp has also extended Kenon a $200 million line of credit as well as $100 million in capital.

Potash and specialty chemicals maker Israel Chemicals (ICL) and Oil Refineries, Israel’s biggest refinery, which are the company’s strongest assets, will remain a part of Israel Corp.

Now in what has taken many by surprise Israel Corp has said that it will also offer Kenon’s shares for sale in Tel Aviv at a $1.5 billion valuation in addition to the NYSE. Its stock jumped 3.2% on the TASE when the news broke rising to 2, 004 shekels ($536.09) per share.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Advertisement
cialis cialis satış